Intellectual Property India Publishes Patent Application for “pharmaceutical Nanoparticle Composition Comprising Ubrogepant And Administration Thereof”

MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202541018501 A) filed by Vignesh Mohan on March 03, 2025, for “pharmaceutical Nanoparticle Composition Comprising Ubrogepant And Administration Thereof”.

Inventors include Vignesh Mohan; and Dr Anil M. Pethe.

The application for the patent was published on September 04, 2026, under issue no. 36/2026.

Abstract: ABSTRACT “PHARMACEUTICAL NANOPARTICLE COMPOSITION COMPRISING UBROGEPANT AND ADMINISTRATION THEREOF” The present invention relates to Nasal nanoparticle inhalation composition of Ubrogepant or its salts or derivatives thereof, the dose ranges between about 0.01 mg to about 50 mg; the particle size range is between about 50 nm and about 600 nm. Nanoparticles are prepared using polymers such as Poly(lactic-co-glycolic) acid or PLGA; solvents such as polyvinyl alcohol.

Disclaimer: Curated by HT Syndication.